ABBV

ABBVIE
D

ABBV

179.990
USD
1.54
(0.86%)
Market Closed
Volume
72,990
EPS
11
Div Yield
3.48
P/E
63
Market Cap
318,067,586,737
OverviewSignalsIdeasNews
Signals
Related Instruments
    AMGN
    AMGN
    0.38
    (0.14%)
    264.35 USD
    BMY
    BMY
    0.180
    (0.31%)
    57.750 USD
    GSK
    GSK
    -0.060
    (-0.18%)
    34.020 USD
    JNJ
    JNJ
    0.560
    (0.39%)
    145.790 USD
    LLY
    LLY
    -3.40
    (-0.43%)
    793.00 USD
    MRK
    MRK
    0.100
    (0.10%)
    99.460 USD
    NVO
    NVO
    -1.380
    (-1.55%)
    87.440 USD
    PFE
    PFE
    0.000
    (0.00%)
    26.710 USD
    SNY
    SNY
    -0.110
    (-0.23%)
    48.300 USD
    More
News

Title: ABBVIE

Sector: Healthcare
Industry: Drug Manufacturers - General
AbbVie Inc. is an American biopharmaceutical firm that engages in research-based development, marketing and sales of pharmaceutical products. It was founded in 2011 as a spin-off of Abbott Laboratories, which planned to separate into two publicly traded companies. The new Abbott Laboratories would specialize in diversified products, including medical devices, diagnostic equipment and nutrition products, while AbbVie was slated to operate as a research-based pharmaceutical manufacturer. The separation came into effect on January 1, 2013. AbbVie was listed on the New York Stock Exchange on January 2, 2013. According to company statistics from December 2015, AbbVie Inc. employed more than 28,000 people globally and provided products to individuals in more than 170 countries. According to updated statistics from October 2022, the company now employs over 50,000 globally, reflecting impressive growth in key markets.